GSK-269962A

DB17030ExperimentalSmall molecule

GSK-269962A is a Rho kinase (ROCK) inhibitor with both ROCK1 and ROCK2 affinity.

Chemical structure of GSK-269962A
Formula / weight
C29H30N8O5 · 570.61 g/mol (avg)
Also known as
Benzamide, n-(3-((2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1h-imidazo(4,5-c)pyridin-6-yl)oxy)phenyl)-4-(2-(4-morpholinyl)ethoxy)- · N-(3-((2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1h-imidazo(4,5-c)pyridin-6-yl)oxy)phenyl)-4-(2-(4-morpholinyl)ethoxy)benzamide
Code names
GSK-269962 · GSK-269962A · GSK269962B

Resolves to

Compound
UNIIF89KMM7TE2CAS850664-21-0ChEMBLCHEMBL220241
Structure
InChIKeyYOVNFNXUCOWYSG-UHFFFAOYSA-NSMILESCCN1C2=C(C=NC(OC3=CC(NC(=O)C4=CC=C(OCCN5CCOCC5)C=C4)=CC=C3)=C2)N=C1C1=NON=C1N
Targets
O75116ROCK2Q13464ROCK1

What you can answer from here — as of March 06, 2025

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
7+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with GSK-269962A, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In